Gadallah M F, Ramdeen G, Torres C, Mignone J, Patel D, Mitchell L, Tatro S
Department of Medicine, University of Florida Medical Center, Jacksonville, USA.
Adv Perit Dial. 2000;16:199-203.
The role of vancomycin and other antibiotics in treatment of acute peritonitis in peritoneal dialysis patients is well established. However, the role of preoperative vancomycin or cephalosporins in preventing early infection in newly placed peritoneal dialysis catheters remains controversial. We performed a prospective randomized study to examine the role of vancomycin or cefazolin prophylaxis in decreasing the incidence of postoperative peritonitis. Over 8-year period, 265 patients undergoing 305 permanent peritoneal catheter placement procedures were randomized into three groups. Group I (103 procedures) received a single intravenous (i.v.) dose of 1000 mg vancomycin 12 hours before the peritoneal catheter placement procedure. Group II (102 procedures) received a single i.v. dose of 1000 mg of Ancef (cefazolin) 3 hours before the procedure. Group III (100 procedures) received no antibiotics preoperatively for a least one week before the procedure. Patients were monitored for peritonitis during the following 14 days. Peritonitis developed in 1 patient (1%) in Group I (vancomycin group) compared to 12 patients (12%) in Group III (control group), p = 0.002, and in 9 patients (9%) in Group II (cefazolin group) compared to Group III, p = 0.68. We conclude that the use of preoperative single-dose i.v. vancomycin prophylaxis for permanent peritoneal dialysis catheter placement reduces the risk of postoperative peritonitis. Cefazolin did not achieve a statistically significant difference from the control group and may not provide adequate prophylaxis.
万古霉素及其他抗生素在腹膜透析患者急性腹膜炎治疗中的作用已得到充分证实。然而,术前使用万古霉素或头孢菌素预防新置入腹膜透析导管早期感染的作用仍存在争议。我们进行了一项前瞻性随机研究,以探讨万古霉素或头孢唑林预防在降低术后腹膜炎发生率方面的作用。在8年期间,265例接受305次永久性腹膜导管置入手术的患者被随机分为三组。第一组(103例手术)在腹膜导管置入手术前12小时静脉注射1000毫克万古霉素单次剂量。第二组(102例手术)在手术前3小时静脉注射1000毫克安赛福(头孢唑林)单次剂量。第三组(100例手术)在手术前至少一周未接受抗生素治疗。在接下来的14天内对患者进行腹膜炎监测。第一组(万古霉素组)有1例患者(1%)发生腹膜炎,而第三组(对照组)有12例患者(12%)发生腹膜炎,p = 0.002;第二组(头孢唑林组)有9例患者(9%)发生腹膜炎,与第三组相比,p = 0.68。我们得出结论,术前单次静脉注射万古霉素预防永久性腹膜透析导管置入可降低术后腹膜炎的风险。头孢唑林与对照组相比未达到统计学显著差异,可能无法提供充分的预防作用。